Fig. 1From: Efficacy of a nootropic spearmint extract on reactive agility: a randomized, double-blind, placebo-controlled, parallel trialCONSORT diagram for Study Participants. A total of 485 participants were screened. Healthy active young men and women were randomly assigned to one of two treatments, 0 PLA or 900 mg/day PSE (Total randomized N = 142; N = 69 (PLA), N = 73 (PSE)). A total of 54 and 52 subjects completed the trial in the PLA and 900 mg/day PSE groups, respectively. Abbreviations: PSE, proprietary spearmint extract; PLA, placebo; AE, adverse eventBack to article page